Stoke Therapeutics (STOK) Short Interest Ratio & Short Volume → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free STOK Stock Alerts $12.80 +1.25 (+10.82%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Stoke Therapeutics Short Interest DataCurrent Short Volume8,310,000 sharesPrevious Short Volume5,530,000 sharesChange Vs. Previous Month+50.27%Dollar Volume Sold Short$91.66 millionShort Interest Ratio / Days to Cover6.6Last Record DateApril 30, 2024Outstanding Shares52,120,000 sharesPercentage of Shares Shorted15.94%Today's Trading Volume952,119 sharesAverage Trading Volume797,279 sharesToday's Volume Vs. Average119% Short Selling Stoke Therapeutics ? Sign up to receive the latest short interest report for Stoke Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSTOK Short Interest Over TimeSTOK Days to Cover Over TimeSTOK Percentage of Float Shorted Over Time Ad InvestorPlaceHow to Make 100X on the AI BoomFor over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs Stoke Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,310,000 shares $91.66 million +50.3%N/A6.6 $11.03 4/15/20245,530,000 shares $67.52 million +11.7%N/A4.8 $12.21 3/31/20244,950,000 shares $66.83 million +39.4%15.0%4.9 $13.50 3/15/20243,550,000 shares $22.68 million -5.6%12.8%6.3 $6.39 2/29/20243,760,000 shares $29.10 million -5.3%13.5%16.7 $7.74 2/15/20243,970,000 shares $21.08 million -3.9%14.3%18.2 $5.31 Get the Latest News and Ratings for STOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Stoke Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,130,000 shares $19.99 million +20.1%14.8%20.6 $4.84 1/15/20243,440,000 shares $17.61 million +3.6%12.4%16.4 $5.12 12/31/20233,320,000 shares $17.46 million +4.1%11.9%14.7 $5.26 12/15/20233,190,000 shares $16.33 million -20.7%11.5%14 $5.12 11/30/20234,020,000 shares $15.24 million -1.5%14.5%18.6 $3.79 11/15/20234,080,000 shares $18.81 million -5.3%14.7%21 $4.61 10/31/20234,310,000 shares $16.42 million -4.7%15.9%19.1 $3.81 10/15/20234,520,000 shares $18.51 million -1.7%16.7%11.3 $4.10 9/30/20234,600,000 shares $18.12 million -3.6%17.0%11.3 $3.94 9/15/20234,770,000 shares $23.75 million +3.0%16.5%11.9 $4.98 8/31/20234,630,000 shares $26.02 million +3.8%16.0%10.7 $5.62 8/15/20234,460,000 shares $24.84 million -18.9%15.4%10.1 $5.57 7/31/20235,500,000 shares $36.52 million -3.7%19.1%13.3 $6.64 7/15/20235,710,000 shares $57.96 million -0.2%19.9%17.4 $10.15 6/30/20235,720,000 shares $60.80 million +4.8%19.9%23.5 $10.63 6/15/20235,460,000 shares $70.60 million +4.4%19.0%21.2 $12.93 5/31/20235,230,000 shares $58.58 million +7.2%18.2%23.3 $11.20 5/15/20234,880,000 shares $57.29 million +3.6%17.0%20.8 $11.74 4/30/20234,710,000 shares $41.87 million +20.8%16.4%20.2 $8.89 4/15/20233,900,000 shares $31.86 million -8.7%13.6%13.4 $8.17 3/31/20234,270,000 shares $35.57 million +8.4%15.9%14.7 $8.33 3/15/20233,940,000 shares $36.05 million +1.3%14.7%12 $9.15 2/28/20233,890,000 shares $34.58 million No Change14.5%11.9 $8.89 2/15/20233,890,000 shares $35.05 million +1.8%16.3%12.1 $9.01 1/31/20233,820,000 shares $38.05 million -1.0%16.0%9.5 $9.96 1/15/20233,860,000 shares $37.64 million +0.5%16.2%11.4 $9.75 12/30/20223,840,000 shares $35.44 million +6.7%16.1%10.8 $9.23 12/15/20223,600,000 shares $29.88 million -1.6%15.1%11.1 $8.30 11/30/20223,660,000 shares $27.60 million -13.3%16.7%11.2 $7.54 11/15/20224,220,000 shares $42.16 million -8.1%19.2%13.3 $9.99 10/31/20224,590,000 shares $68.16 million -10.9%21.1%19.5 $14.85 10/15/20225,150,000 shares $61.34 million -5.5%23.7%22.5 $11.91 9/30/20225,450,000 shares $69.98 million +3.6%25.0%25 $12.84 9/15/20225,260,000 shares $86.74 million -1.5%24.2%24.5 $16.49Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. STOK Short Interest - Frequently Asked Questions What is Stoke Therapeutics' current short interest? Short interest is the volume of Stoke Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 8,310,000 shares of STOK short. Learn More on Stoke Therapeutics' current short interest. What is a good short interest ratio for Stoke Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. STOK shares currently have a short interest ratio of 7.0. Learn More on Stoke Therapeutics's short interest ratio. Is Stoke Therapeutics' short interest increasing or decreasing? Stoke Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 8,310,000 shares, an increase of 50.3% from the previous total of 5,530,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Stoke Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Stoke Therapeutics: GH Research PLC (5.05%), Olema Pharmaceuticals, Inc. (15.02%), Calliditas Therapeutics AB (publ) (0.03%), Phathom Pharmaceuticals, Inc. (41.92%), Pharming Group (0.01%), Lyell Immunopharma, Inc. (16.91%), ORIC Pharmaceuticals, Inc. (15.19%), IGM Biosciences, Inc. (29.87%), Silence Therapeutics plc (0.99%), CureVac (4.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Stoke Therapeutics stock? Short selling STOK is an investing strategy that aims to generate trading profit from Stoke Therapeutics as its price is falling. STOK shares are trading up $1.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Stoke Therapeutics? A short squeeze for Stoke Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STOK, which in turn drives the price of the stock up even further. How often is Stoke Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STOK, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: GH Research Short Interest Olema Pharmaceuticals Short Interest Calliditas Therapeutics AB (publ) Short Interest Phathom Pharmaceuticals Short Interest Pharming Group Short Interest Lyell Immunopharma Short Interest ORIC Pharmaceuticals Short Interest IGM Biosciences Short Interest Silence Therapeutics Short Interest CureVac Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:STOK) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityBuy this small stock before coming AI Tidal WaveChaikin AnalyticsRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon’s New Device is About to Shock the WorldInvestorPlace